Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 119.0 | 43 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 393.0 | 49 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 301.5 | 44 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 158.0 | 37 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | b-NGF | 183.0 | 31 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 64.0 | 39 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 36.0 | 43 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 41.0 | 52 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 25.0 | 61 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 93.0 | 70 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 94.5 | 60 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 44.0 | 48 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 30.0 | 53 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 79.0 | 56 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 80.0 | 36 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 34.0 | 55 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 71.0 | 63 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 214.0 | 49 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 210.0 | 42 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 93.0 | 43 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 125.0 | 36 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 55.5 | 34 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | b-NGF | 47.0 | 49 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 34.0 | 57 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | b-NGF | 26.5 | 58 |